Brief: SMS Pharmaceuticals Says Completion Of USFDA Inspection At Vizag Manufacturing Facility
12/12/2025 14:34
Dec 12 (Reuters) - SMS Pharmaceuticals Ltd SMSP.NS: COMPLETION OF USFDA INSPECTION AT VIZAG MANUFACTURING FACILITY USFDA INSPECTION CONCLUDED WITH ONE MINOR OBSERVATION IN FORM 483 Source text: [ID:] Further company coverage: SMSP.NS ((Reuters.Briefs@thomsonreuters.com;))
Recent news on SMS Pharmaceuticals
See all newsBrief: SMS Pharmaceuticals Ltd Q2 Consol Net Profit INR 398.5 Million
Brief: SMS Pharmaceuticals March-Quarter Consol Net Profit 327.1 Million Rupees
Brief: Sms Pharmaceuticals Says Tax Demand Reduced To 4 Million Rupees From 71.9 Million Rupees
Advisory: Alert incorrectly tagged to SMS Phramaceuticals withdrawn
Brief: SMS Pharmaceuticals Says Completion Of USFDA Inspection At Vizag Manufacturing Facility